trial · primary record
Mavorixafor
Acquired Primary Autoimmune and Idiopathic Chronic Neutropenia Disorders
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2029-01-30 |
| Primary endpoint | Number of Participants With Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT07902830 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:55.027Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902830
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.